• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Profound Medical Corp (NQ: PROF )

7.350 +0.080 (+1.10%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,743
Open 7.380
Bid (Size) 7.350 (1)
Ask (Size) 8.780 (16)
Prev. Close 7.270
Today's Range 7.250 - 7.430
52wk Range 7.110 - 11.69
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Profound Medical to Release Third Quarter 2024 Financial Results on November 7 – Conference Call to Follow
October 17, 2024
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Appoints Tom Tamberrino as Chief Commercial Officer
October 16, 2024
From Profound Medical Corp.
Via GlobeNewswire

Performance

YTD
-7.55%
-7.55%
1 Month
-7.20%
-7.20%
3 Month
-22.63%
-22.63%
6 Month
-0.88%
-0.88%
1 Year
-23.44%
-23.44%

More News

Read More
iAccess Alpha's Buyside Best Ideas Virtual Fall Conference September 24-25, 2024
September 20, 2024
Via ACCESSWIRE
Profound Medical: Q4 Earnings Insights
March 07, 2024
Via Benzinga
Profound Medical’s PRO-Talk Live! Event Features the Present and Future of TULSA
September 16, 2024
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical to Participate in Lake Street’s Best Ideas Growth Conference
September 04, 2024
From Profound Medical Corp.
Via GlobeNewswire
PROF Stock Earnings: Profound Medical Beats EPS, Misses Revenue for Q2 2024
August 08, 2024
Via InvestorPlace
Profound Medical Announces Second Quarter 2024 Financial Results
August 08, 2024
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical to Release Second Quarter 2024 Financial Results on August 8 – Conference Call to Follow
July 18, 2024
From Profound Medical Corp.
Via GlobeNewswire
Microsoft To Rally Around 6%? Here Are 10 Top Analyst Forecasts For Tuesday
July 16, 2024
Via Benzinga
Profound Medical Announces Category 1 CPT Codes Proposed CY2025 Rule for TULSA to Treat Prostate Diseases
July 11, 2024
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Annual General Meeting of Shareholders Voting Results
May 15, 2024
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Receives U.S. FDA 510(k) Clearance for ‘Contouring Assistant’ AI Module that Enables Creation of an Automated TULSA Treatment Plan
May 14, 2024
From Profound Medical Corp.
Via GlobeNewswire
PROF Stock Earnings: Profound Medical Beats EPS, Misses Revenue for Q1 2024
May 09, 2024
Via InvestorPlace
Profound Medical Announces First Quarter 2024 Financial Results and Issues Full-Year 2024 Revenue Guidance
May 09, 2024
From Profound Medical Corp.
Via GlobeNewswire
Growing Body of Clinical Evidence Points to the Potential of Profound Medical’s TULSA Procedure Becoming a Mainstream Treatment Modality Across the Entire Prostate Disease Spectrum
May 06, 2024
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical to Release First Quarter 2024 Financial Results on May 9 – Conference Call to Follow
April 22, 2024
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference
April 09, 2024
From Profound Medical Corp.
Via GlobeNewswire
PROF Stock Earnings: Profound Medical Misses EPS, Beats Revenue for Q4 2023
March 07, 2024
Via InvestorPlace
Profound Medical Announces Fourth Quarter and Full Year 2023 Financial Results
March 07, 2024
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical to Participate in Barclays 26th Annual Global Healthcare Conference
March 04, 2024
From Profound Medical Corp.
Via GlobeNewswire
Earnings Scheduled For March 7, 2024
March 07, 2024
Via Benzinga
Profound Medical in Collaboration with Siemens Healthineers to Further Expand Physician and Patient Access to the TULSA Procedure
February 27, 2024
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical to Release Fourth Quarter and Full Year 2023 Financial Results on March 7 – Conference Call to Follow
February 15, 2024
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Announces Non-Brokered Private Placement
January 16, 2024
From Profound Medical Corp.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap